Catalyst OrthoScience

Catalyst OrthoScience

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $37M

Overview

Catalyst OrthoScience is a commercial-stage orthopedic device company specializing in next-generation shoulder replacement systems. Founded in 2015 and based in Naples, Florida, the company differentiates itself through its science-driven, bone-preserving implant designs, including its stemless, elliptical humeral head and simplified reverse shoulder system. With a focus on clinical validation and enabling efficiency in ASCs, Catalyst aims to address key challenges in shoulder arthroplasty by offering solutions that promote anatomic restoration and faster patient recovery.

OrthopedicsMusculoskeletal

Technology Platform

A shoulder arthroplasty platform centered on an elliptical (non-spherical) humeral head design, stemless/canal-sparing fixation via a multiplanar osteotomy, and a simplified single-tray reverse system, all aimed at anatomic restoration and bone preservation.

Funding History

2
Total raised:$37M
Series B$25M
Series A$12M

Opportunities

The rapid migration of shoulder arthroplasty to ambulatory surgery centers (ASCs) creates a strong demand for efficient, simplified implant systems that facilitate faster patient recovery, which aligns with Catalyst's product design.
Additionally, the growing clinical preference for bone-preserving, stemless anatomic implants presents a significant market shift that Catalyst's technology is uniquely positioned to address.

Risk Factors

The company faces intense competition from large, established orthopedic giants with deep surgeon relationships and extensive resources.
Success is also highly dependent on convincing surgeons to adopt a new surgical technique and implant design, which is a slow process in the traditionally conservative orthopedic field.

Competitive Landscape

Catalyst competes in the crowded shoulder arthroplasty market dominated by multinational giants like Stryker, Zimmer Biomet, Johnson & Johnson (DePuy Synthes), and Smith & Nephew. Its primary competitive differentiation is its focus on elliptical head anatomy and stemless fixation, competing against other niche players with stemless offerings (e.g., Arthrex's Univers Revers, Exactech's Equinoxe Stemless) and the broader market of traditional stemmed spherical implants.